Lente insulin

File:Human-insulin-hexamer-3D-ribbons.png

3D structure of human insulin hexamer

Lente insulin is a type of intermediate-acting insulin used in the management of diabetes mellitus. It is designed to mimic the body's natural pattern of insulin release and is typically administered to help control blood glucose levels throughout the day.

History

Lente insulin was developed as part of efforts to create insulin formulations with varying durations of action. It was introduced in the mid-20th century and became a popular choice for patients requiring insulin therapy due to its intermediate duration of action.

Composition

Lente insulin is a suspension of insulin zinc crystals in an acetate buffer. The formulation contains both amorphous and crystalline insulin, which contributes to its intermediate duration of action. The presence of zinc helps stabilize the insulin molecules, allowing for a slower release into the bloodstream.

Mechanism of Action

Lente insulin works by facilitating the uptake of glucose into cells, particularly in the liver, muscle, and adipose tissue. This action helps lower blood glucose levels and is essential for the management of diabetes. The intermediate action of Lente insulin is due to the gradual dissolution of the insulin zinc crystals, providing a steady release of insulin over time.

Administration

Lente insulin is typically administered via subcutaneous injection. The timing and dosage depend on the individual's needs, blood glucose monitoring, and the advice of a healthcare provider. It is often used in combination with other types of insulin to achieve optimal blood glucose control.

Advantages and Disadvantages

Advantages

• Provides a more stable and prolonged insulin action compared to short-acting insulins.
• Can be used in combination with other insulin types for tailored diabetes management.

Disadvantages

• May not provide adequate control of postprandial blood glucose spikes.
• Requires careful monitoring and adjustment to avoid hypoglycemia.

Related Pages

• Diabetes mellitus
• Insulin therapy
• Insulin analogs
• Hypoglycemia